EUVIMEDEUVIMED entdecken
Netzwerk-Metaanalyse

Optimal revascularization strategy in patients with acute coronary syndrome and multivessel disease: insights from a network meta-analysis

Andrea Milzi, Stefano Benenati, Antonio Landi, Florian Kahles, Italo Porto, Marco Valgimigli

Clinical Research in Cardiology · 2026

DOI: 10.1007/s00392-025-02693-6 ↗

Kurz gefasst

Netzwerk-Metaanalyse in der Zeitschrift Clinical Research in Cardiology, 2026. Verfasst von Andrea Milzi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale (EOC), Via Tesserete 48, CH-6900, Lugano, Switzerland. andrea.milzi@eoc.ch. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Myocardial Revascularization, Coronary Artery Disease, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coronary multivessel disease (MVD) affects approximately 50% of the patients presenting with acute coronary syndrome (ACS). The optimal revascularization strategy after culprit lesion treatment, including the optimal method to select non-culprit lesions amenable to revascularization, remains unsettled. This study sought to compare culprit-only revascularization, angiography-guided complete revascularization, and physiology-guided complete revascularization in multivessel disease (MVD) patients with acute coronary syndrome (ACS). We searched PUBMED and Web of Science for randomized controlled trials investigating outcomes following culprit-only revascularization, angiography-guided complete revascularization or physiology-guided complete revascularization in patients with ACS and MVD. We identified 14 randomized studies and 11,871 participants with ACS and MVD, of whom 5090 underwent culprit-only intervention, 3641 angiography-guided complete revascularization, 3140 physiology-guided complete revascularization). Major adverse cardiac events (MACE) were lower in both angiography- (IRR 0.60, 95%-CI 0.46-0.79) or physiology-guided (IRR 0.65, 95%-CI 0.50-0.85) complete revascularization compared with culprit-only revascularization. P-score for treatment ranking was higher for angiography- (0.834) than physiology-guidance (0.666). The estimated effects for all-cause and cardiovascular death vs. culprit-only revascularization were 0.89 (95%-CI 0.61-1.30) and 0.82 (95%-CI 0.48-1.40) for angiography-guidance, and 0.78 (95%-CI 0.55-1.11) and 0.64 (95%-CI 0.40-1.01) for physiology-guidance, respectively. For both all-cause death and cardiovascular death, the highest benefit was estimated for physiology-guidance (P-scores respectively 0.821 and 0.870). In patients with ACS and MVD, both angiography- and physiology-guided complete revascularization are superior to culprit-only revascularization with respect to MACE reduction. Angiography-guidance and physiology-guidance were comparable for future events prevention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Coronary SyndromeMyocardial RevascularizationCoronary Artery DiseasePercutaneous Coronary InterventionHumansCoronary AngiographyTreatment Outcome

Stichwörter der Autor:innen

Acute coronary syndromeComplete revascularizationCoronary artery diseaseCoronary physiologyPercutaneous coronary intervention

Autor:innen und Institutionen

  • Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale (EOC), Via Tesserete 48, CH-6900, Lugano, Switzerland. andrea.milzi@eoc.ch.
  • Faculty of Biomedical Sciences, University of Italian Switzerland, Lugano, Switzerland. andrea.milzi@eoc.ch.
  • Department of Internal Medicine (Di.M.I.), University of Genoa, Genoa, Italy.
  • Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale (EOC), Via Tesserete 48, CH-6900, Lugano, Switzerland.
  • Faculty of Biomedical Sciences, University of Italian Switzerland, Lugano, Switzerland.
  • Department of Cardiology, University Hospital of the RWTH Aachen, Aachen, Germany.

Zitieren

APA

Milzi, A., Benenati, S., Landi, A., Kahles, F., Porto, I., & Valgimigli, M. (2026). Optimal revascularization strategy in patients with acute coronary syndrome and multivessel disease: insights from a network meta-analysis. Clinical Research in Cardiology. https://doi.org/10.1007/s00392-025-02693-6

Vancouver

Milzi A, Benenati S, Landi A, Kahles F, Porto I, Valgimigli M. Optimal revascularization strategy in patients with acute coronary syndrome and multivessel disease: insights from a network meta-analysis. Clinical Research in Cardiology. 2026. doi:10.1007/s00392-025-02693-6

BibTeX
@article{Milzi2026,
  author = {Milzi, Andrea and Benenati, Stefano and Landi, Antonio and Kahles, Florian and Porto, Italo and Valgimigli, Marco},
  title = {Optimal revascularization strategy in patients with acute coronary syndrome and multivessel disease: insights from a network meta-analysis},
  journal = {Clinical Research in Cardiology},
  year = {2026},
  doi = {10.1007/s00392-025-02693-6}
}
Kostenlos starten →